Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie R Favret

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|March 11, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor controlCarlos R Detrés Román, Michael W Rudloff, Frank Revetta, et al.
Journal for Immunotherapy of Cancer|October 3, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor controlCarlos R Detrés Román, Megan M Erwin, Michael W Rudloff, et al.
Nature Immunology|August 3, 2023
Hallmarks of CD8<sup>+</sup> T cell dysfunction are established within hours of tumor antigen encounter before cell divisionMichael W Rudloff, Paul Zumbo, Natalie R Favret, et al.
Cancer Immunology Research|October 16, 2023
Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional StateJessica J Roetman, Megan M Erwin, Michael W Rudloff, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapyLincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumorsMegan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fatesNatalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|March 11, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor controlCarlos R Detrés Román, Michael W Rudloff, Frank Revetta, et al.
Journal for Immunotherapy of Cancer|October 3, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor controlCarlos R Detrés Román, Megan M Erwin, Michael W Rudloff, et al.
Nature Immunology|August 3, 2023
Hallmarks of CD8<sup>+</sup> T cell dysfunction are established within hours of tumor antigen encounter before cell divisionMichael W Rudloff, Paul Zumbo, Natalie R Favret, et al.
Cancer Immunology Research|October 16, 2023
Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional StateJessica J Roetman, Megan M Erwin, Michael W Rudloff, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapyLincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumorsMegan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fatesNatalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Pageof 1